Geron Corp.: How Concerned Should We Be About Rytelo Sales?
Geron Corp's Rytelo launch & robust pipeline offer a compelling investment opportunity, despite stock challenges. Click here ...
Targeted Oncology16d
Transfusion Independence Serves as Key End Point for LR-MDS Trials
Saeed Sadeghi, MD, clinical professor of medicine at the David Geffen School of Medicine at UCLA in Los Angeles, California, discusses the findings on transfusion independence achieved with treatment ...
ki.se17d
Translational and clinical research in acute myeloid leukemia – Team Martin Jädersten
The Martin Jädersten group is investigating biological and clinical aspects of acute myeloid leukemia (AML) and runs academic trials exploring novel treatment strategies. The team leader Martin ...